FDA Vaccines Chief Departure Signals Shift in Agency Leadership. Dr. Vinay Prasad, the controversial head of the FDA's vaccine division, will depart the agency in April following a tenure marked by significant disagreement over vaccine approval standards and regulatory approaches. His departure comes amid ongoing debate within the medical and scientific communities regarding the balance between expedited approval processes and comprehensive safety evaluations. Prasad's tenure was characterized by efforts to implement stricter requirements for vaccine authorization, which faced pushback from pharmaceutical companies and some public health officials who argued such measures could slow critical drug development. The timing of his exit coincides with broader discussions about FDA regulatory philosophy and how the agency should handle future vaccine approvals.